16:37 EST Monte Rosa Therapeutics (GLUE) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa Therapeutics price target raised to $37 from $27.50 at Piper Sandler
- Monte Rosa Therapeutics Prices $300 Million Public Offering
- Monte Rosa Therapeutics 11.125M share Secondary priced at $24.00
- Monte Rosa Therapeutics Ends Current ATM Equity Program
- Monte Rosa Therapeutics announces $200M common stock offering
